skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Systemic Therapy for Melanoma: ASCO Guideline
Material Type:
Artigo
Adicionar ao Meu Espaço

Systemic Therapy for Melanoma: ASCO Guideline

Seth, Rahul ; Messersmith, Hans ; Kaur, Varinder ; Kirkwood, John M ; Kudchadkar, Ragini ; McQuade, Jennifer Leigh ; Provenzano, Anthony ; Swami, Umang ; Weber, Jeffrey ; Alluri, Krishna C ; Agarwala, Sanjiv ; Ascierto, Paolo A ; Atkins, Michael B ; Davis, Nancy ; Ernstoff, Marc S ; Faries, Mark B ; Gold, Jason S ; Guild, Samantha ; Gyorki, David E ; Khushalani, Nikhil I ; Meyers, Michael O ; Robert, Caroline ; Santinami, Mario ; Sehdev, Amikar ; Sondak, Vernon K ; Spurrier, Gilliosa ; Tsai, Katy K ; van Akkooi, Alexander ; Funchain, Pauline

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3947-3970 [Periódico revisado por pares]

United States

Texto completo disponível

2
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

Robert, Caroline ; Grob, Jean J ; Stroyakovskiy, Daniil ; Karaszewska, Boguslawa ; Hauschild, Axel ; Levchenko, Evgeny ; Chiarion Sileni, Vanna ; Schachter, Jacob ; Garbe, Claus ; Bondarenko, Igor ; Gogas, Helen ; Mandalá, Mario ; Haanen, John B.A.G ; Lebbé, Celeste ; Mackiewicz, Andrzej ; Rutkowski, Piotr ; Nathan, Paul D ; Ribas, Antoni ; Davies, Michael A ; Flaherty, Keith T ; Burgess, Paul ; Tan, Monique ; Gasal, Eduard ; Voi, Maurizio ; Schadendorf, Dirk ; Long, Georgina V

The New England journal of medicine, 2019-08, Vol.381 (7), p.626-636 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

3
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Material Type:
Artigo
Adicionar ao Meu Espaço

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Long, G.V. ; Flaherty, K.T. ; Stroyakovskiy, D. ; Gogas, H. ; Levchenko, E. ; de Braud, F. ; Larkin, J. ; Garbe, C. ; Jouary, T. ; Hauschild, A. ; Chiarion-Sileni, V. ; Lebbe, C. ; Mandalà, M. ; Millward, M. ; Arance, A. ; Bondarenko, I. ; Haanen, J.B.A.G. ; Hansson, J. ; Utikal, J. ; Ferraresi, V. ; Mohr, P. ; Probachai, V. ; Schadendorf, D. ; Nathan, P. ; Robert, C. ; Ribas, A. ; Davies, M.A. ; Lane, S.R. ; Legos, J.J. ; Mookerjee, B. ; Grob, J.-J.

Annals of oncology, 2017-07, Vol.28 (7), p.1631-1639 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

4
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

Subbiah, Vivek ; Kreitman, Robert J ; Wainberg, Zev A ; Cho, Jae Yong ; Schellens, Jan H M ; Soria, Jean Charles ; Wen, Patrick Y ; Zielinski, Christoph ; Cabanillas, Maria E ; Urbanowitz, Gladys ; Mookerjee, Bijoyesh ; Wang, Dazhe ; Rangwala, Fatima ; Keam, Bhumsuk

Journal of clinical oncology, 2018-01, Vol.36 (1), p.7-13 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

5
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Material Type:
Artigo
Adicionar ao Meu Espaço

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Robert, Caroline ; Karaszewska, Boguslawa ; Schachter, Jacob ; Rutkowski, Piotr ; Mackiewicz, Andrzej ; Stroiakovski, Daniil ; Lichinitser, Michael ; Dummer, Reinhard ; Grange, Florent ; Mortier, Laurent ; Chiarion-Sileni, Vanna ; Drucis, Kamil ; Krajsova, Ivana ; Hauschild, Axel ; Lorigan, Paul ; Wolter, Pascal ; Long, Georgina V ; Flaherty, Keith ; Nathan, Paul ; Ribas, Antoni ; Martin, Anne-Marie ; Sun, Peng ; Crist, Wendy ; Legos, Jeff ; Rubin, Stephen D ; Little, Shonda M ; Schadendorf, Dirk

The New England journal of medicine, 2015-01, Vol.372 (1), p.30-39 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

6
Highly Emissive Dye-Sensitized Upconversion Nanostructure for Dual-Photosensitizer Photodynamic Therapy and Bioimaging
Material Type:
Artigo
Adicionar ao Meu Espaço

Highly Emissive Dye-Sensitized Upconversion Nanostructure for Dual-Photosensitizer Photodynamic Therapy and Bioimaging

Xu, Jiating ; Yang, Piaoping ; Sun, Mingdi ; Bi, Huiting ; Liu, Bin ; Yang, Dan ; Gai, Shili ; He, Fei ; Lin, Jun

ACS nano, 2017-04, Vol.11 (4), p.4133-4144 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

7
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Material Type:
Artigo
Adicionar ao Meu Espaço

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib

Long, Georgina V ; Eroglu, Zeynep ; Infante, Jeffrey ; Patel, Sapna ; Daud, Adil ; Johnson, Douglas B ; Gonzalez, Rene ; Kefford, Richard ; Hamid, Omid ; Schuchter, Lynn ; Cebon, Jonathan ; Sharfman, William ; McWilliams, Robert ; Sznol, Mario ; Redhu, Suman ; Gasal, Eduard ; Mookerjee, Bijoyesh ; Weber, Jeffrey ; Flaherty, Keith T

Journal of clinical oncology, 2018-03, Vol.36 (7), p.667-673 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

8
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

Long, Georgina V, MD ; Stroyakovskiy, Daniil, MD ; Gogas, Helen, MD ; Levchenko, Evgeny, MD ; de Braud, Filippo, MD ; Larkin, James, FRCP ; Garbe, Claus, Prof ; Jouary, Thomas, MD ; Hauschild, Axel, Prof ; Grob, Jean-Jacques, Prof ; Chiarion-Sileni, Vanna, MD ; Lebbe, Celeste, Prof ; Mandalà, Mario, MD ; Millward, Michael, Prof ; Arance, Ana, MD ; Bondarenko, Igor, Prof ; Haanen, John B A G, Prof ; Hansson, Johan, Prof ; Utikal, Jochen, Prof ; Ferraresi, Virginia, MD ; Kovalenko, Nadezhda, Prof ; Mohr, Peter, MD ; Probachai, Volodymr, MD ; Schadendorf, Dirk, Prof ; Nathan, Paul, MD ; Robert, Caroline, MD ; Ribas, Antoni, Prof ; DeMarini, Douglas J, PhD ; Irani, Jhangir G, MA ; Swann, Suzanne, PhD ; Legos, Jeffrey J, PhD ; Jin, Fan, MD ; Mookerjee, Bijoyesh, MD ; Flaherty, Keith, MD

The Lancet (British edition), 2015-08, Vol.386 (9992), p.444-451 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

9
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

Long, Georgina V ; Stroyakovskiy, Daniil ; Gogas, Helen ; Levchenko, Evgeny ; de Braud, Filippo ; Larkin, James ; Garbe, Claus ; Jouary, Thomas ; Hauschild, Axel ; Grob, Jean Jacques ; Chiarion Sileni, Vanna ; Lebbe, Celeste ; Mandalà, Mario ; Millward, Michael ; Arance, Ana ; Bondarenko, Igor ; Haanen, John B.A.G ; Hansson, Johan ; Utikal, Jochen ; Ferraresi, Virginia ; Kovalenko, Nadezhda ; Mohr, Peter ; Probachai, Volodymyr ; Schadendorf, Dirk ; Nathan, Paul ; Robert, Caroline ; Ribas, Antoni ; DeMarini, Douglas J ; Irani, Jhangir G ; Casey, Michelle ; Ouellet, Daniele ; Martin, Anne-Marie ; Le, Ngocdiep ; Patel, Kiran ; Flaherty, Keith

The New England journal of medicine, 2014-11, Vol.371 (20), p.1877-1888 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

10
A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors

Bedard, Philippe L ; Tabernero, Josep ; Janku, Filip ; Wainberg, Zev A ; Paz-Ares, Luis ; Vansteenkiste, Johan ; Van Cutsem, Eric ; Pérez-García, José ; Stathis, Anastasios ; Britten, Carolyn D ; Le, Ngocdiep ; Carter, Kirsten ; Demanse, David ; Csonka, Denes ; Peters, Malte ; Zubel, Angela ; Nauwelaerts, Heidi ; Sessa, Cristiana

Clinical cancer research, 2015-02, Vol.21 (4), p.730-738 [Periódico revisado por pares]

United States

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (849)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (913)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1993  (13)
  2. 1993Até2000  (24)
  3. 2001Até2008  (297)
  4. 2009Até2017  (401)
  5. Após 2017  (179)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (878)
  2. Japonês  (112)
  3. Espanhol  (25)
  4. Alemão  (4)
  5. Francês  (3)
  6. Dinamarquês  (1)
  7. Italiano  (1)
  8. Coreano  (1)
  9. Tcheco  (1)
  10. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.